At #AACR24 , new clinical data demonstrated the promise of therapeutic vaccines for aggressive cancers, including pancreatic and head and neck cancers. Learn more on the #AACRBlog : bit.ly/3TYME8k

To raise awareness about the higher incidence of prostate cancer in Black men, researchers presented a video at #AACR24 pairing a Black pastor with a urologist that led to 93% of viewers saying they would get screened: Read more on the #AACRBlog : bit.ly/3TYewt2.

Therapeutic vaccines showed promise against aggressive cancers in clinical trials presented at #AACR24 . Learn more on the #AACRBlog : bit.ly/3UfqqAa #AACR24

In a poster at #AACR24 , Eddie Cliff revealed that of the 129 cancer drug-indication pairs approved under FDA’s accelerated approval pathway between 2013-2023, only 43% demonstrated a clinical benefit in confirmatory trials. Read more on the #AACRBlog : bit.ly/3vLo9TX

June is Cancer #ImmunotherapyMonth . Thanks to dramatic advances in the field, the ability to create new therapies that benefit more patients is here right now. In January, I shared my perspective on the future of immunotherapy with the #AACRBlog :
bit.ly/3qzOn97
#CIM23

In 2024, I’d like more scientists to recognize that they don’t have to carry the weight of addressing disparities alone. Let’s acknowledge that we need a team.

#AACRBlog #Cancer #healthequity

Here are the 2024 Global Scholar-in-Training Awardees (GSITAs) who will be attending the AACR Annual Meeting in San Diego, CA. You can learn more about this program by reading the inspiring insights from our 2023 GSITA alumni below #AACR blog #AACR GlobalScholars #AACR 24 #AACR

For #WomensHistoryMonth , explore how AACR’s Women in Cancer Research (WICR) group has supported women scientists for 25 years. Learn more on the #AACRBlog : bit.ly/43vOYrK Sheila Singh Brain Tumour Lab

Well,, this made me smile.
Such hope-filled, determined statements from leading KRAS researchers

David Tuvenson, Mariano Barbacid, Dafna Bar-Sagi, Frank McCormick Kevan Shokat Andrew Aguirre

Thanks AACR

#AACRBlog KRASKickers #AACR23
vimeo.com/817973736

The first quarter of 2024 brought 14 new U.S. FDA approvals for cancer, including a new type of cell-based immunotherapy for melanoma. Learn more on the #AACRBlog : bit.ly/4cXIV3A

Here is our latest AACR Annual Forecast #AACRBlog on cancer health equity. Thanks to Dr. Rob Winn, a leading expert on this important topic.

Looking for new tools for your own research? Or just want to read about some creative approaches in research? Check out the #AACRBlog 's series, From the Bench! In the first installment: locusts that smell cancer, new protein delivery tools, and more. bit.ly/3OE1tvD

Register by February 2 for discounted rates to attend the inaugural Blood Cancer Discovery Symposium. The Chairs and Editors-in-Chief Kenneth C. Anderson and Riccardo Dalla-Favera discuss this exciting initiative in a recent interview:
bit.ly/42uUL0l
AACR #AACRBlog

The first quarter of 2024 brought 14 new U.S. FDA approvals for cancer, including a new type of cell-based immunotherapy for melanoma. Learn more on the #AACRBlog : bit.ly/49pcgkb

This #MyelomaAwarenessMonth , learn how researchers are striving to improve clinical trials for smoldering #multiplemyeloma . Check out the #AACRBlog : bit.ly/3voeS43

#AACR24 is just 2 days away. The #AACRBlog has a few tips to ensure you get the most out your experience at the premier cancer research meeting: bit.ly/3vt7ULf

The U.S. FDA issued 14 new oncology approvals in the first quarter of 2024, including the first tumor-infiltrating lymphocyte therapy and a new PD-1 inhibitor. Learn more on the #AACRBlog : bit.ly/4ayRFLC

As we wrap up #WomensHistoryMonth , explore how AACR’s Women in Cancer Research (WICR) group has supported women scientists for 25 years. Learn more on the #AACRBlog : bit.ly/3xcbIRk

March highlights from AACR journals: synergy drives drug resistance in AML, stress promotes colorectal cancer, and more. Read the Editors’ Picks on the #AACRBlog : bit.ly/49iPRVK

Register to attend the inaugural Blood Cancer Discovery Symposium. The Chairs and Editors-in-Chief Kenneth C. Anderson and Riccardo Dalla-Favera discuss this exciting initiative in a recent interview:
bit.ly/49DnF0h
AACR #AACRBlog